Skip to main content

Table 2 Multivariate SH model in the training set and the validation set

From: Prognosis prediction in esophageal signet-ring-cell carcinoma: a competing risk analysis

Characteristics

Training Cohort (N = 282)

Validation Cohort (N = 282)

SHR

95% CI

P value

SHR

95% CI

P value

Age

 ≤ 65

Reference

  

Reference

  

 > 65

0.93

0.676–1.28

0.66

1.139

0.823–1.576

0.43

Sex

 Female

Reference

  

Reference

  

 Male

2.309

1.259–4.236

0.007

1.641

0.893–3.017

0.11

Race

 Others

Reference

  

Reference

  

 White

0.712

0.436–1.165

0.18

1.164

0.683–1.985

0.58

Marital status

 Widowed/others

Reference

  

Reference

  

 Divorced/Separated

1.033

0.523–2.042

0.92

0.885

0.448–1.748

0.73

 Married

0.878

0.539–1.428

0.6

0.767

0.469–1.255

0.29

 Single/Unmarried

0.963

0.525–1.766

0.9

0.947

0.539–1.662

0.85

History of Malignancy

 Previously

Reference

  

Reference

  

 Newly

1.897

0.652–5.52

0.24

0.715

0.284–1.802

0.48

Primary Site

 Others

Reference

  

Reference

  

 15-32 cm

1.244

0.625–2.476

0.53

1.55

0.527–4.588

0.43

 33-40 cm

0.647

0.376–1.113

0.12

2.612

1.182–5.772

0.018

Grade

 I-II

Reference

  

Reference

  

 III-IV

1.143

0.485–2.696

0.76

1.314

0.716–2.412

0.38

 Others

1.252

0.5–3.134

0.63

1.184

0.592–2.37

0.63

AJCC Stage

 I

Reference

  

Reference

  

 II

1.564

0.678–3.609

0.29

2.069

0.977–4.38

0.058

 III

1.899

0.769–4.686

0.16

4.336

1.883–9.987

< 0.001

 IV

2.358

0.99–5.614

0.053

3.173

1.435–7.017

0.004

Tumor Size

 T1

Reference

  

Reference

  

 T2

1.117

0.599–2.085

0.73

0.676

0.337–1.355

0.27

 T3

0.799

0.489–1.306

0.37

0.388

0.218–0.691

0.001

 T4

0.819

0.439–1.529

0.53

0.441

0.235–0.827

0.011

 TX

0.608

0.319–1.157

0.13

0.65

0.32–1.32

0.23

Node Status

 N0

Reference

  

Reference

  

 N1

1.103

0.685–1.775

0.69

0.71

0.444–1.136

0.15

 N2

0.952

0.51–1.779

0.88

0.548

0.285–1.054

0.072

 N3/NX

1.128

0.54–2.354

0.75

0.588

0.251–1.376

0.22

Regional Nodes Examined

 0

Reference

  

Reference

  

 0–10

1.286

0.653–2.533

0.47

0.962

0.297–3.112

0.95

 11–60

1.007

0.482–2.106

0.98

0.408

0.128–1.304

0.13

Positive Lymph Nodes

 0

Reference

  

Reference

  

 0–2

1.006

0.523–1.936

0.99

1.92

0.809–4.588

0.14

 3–35

1.537

0.706–3.346

0.28

2.949

0.94–9.253

0.064

Bone Metastases

 NO/Unknown

Reference

  

Reference

  

 YES

1.105

0.614–1.988

0.74

2.125

1.215–3.717

0.008

Liver Metastases

 NO/Unknown

Reference

  

Reference

  

 YES

1.573

0.848–2.919

0.15

2.238

1.301–3.85

0.004

Lung Metastases

 NO/Unknown

Reference

  

Reference

  

 YES

2.364

1.187–4.709

0.014

1.552

0.743–3.241

0.24

Surgery

 NO

Reference

  

Reference

  

 YES

0.497

0.271–0.91

0.024

0.331

0.116–0.948

0.039

Radiotherapy

 NO

Reference

  

Reference

  

 YES

1.098

0.616–1.956

0.75

1.991

1.014–3.906

0.045

Chemotherapy

 NO

Reference

  

Reference

  

 YES

0.82

0.498–1.351

0.44

0.757

0.491–1.168

0.21

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us